Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is -3.27% vs -19.80% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 5.21% vs -35.64% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is 6.15% vs -36.37% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is -31.43% vs 0.00% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Hubei Jumpcan Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is -3.27% vs -19.80% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -33.17% vs -7.19% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 5.21% vs -35.64% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -47.22% vs -6.48% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is 6.15% vs -36.37% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -48.33% vs -2.51% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -31.43% vs 0.00% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -65.22% vs 102.94% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






